twenty first meeting parties decides noting appreciation work done technology economic assessment panel medical technical options committee mindful that according decision iv use chlorofluorocarbons metered dose inhalers qualify essential use technically economically feasible alternatives substitutes available acceptable standpoint environment health noting technology economic assessment panel conclusion technically satisfactory alternatives chlorofluorocarbon based metered dose inhalers available therapeutic formulations treating asthma chronic obstructive pulmonary disease taking account technology economic assessment panel analysis recommendations essential use exemptions controlled substances manufacture metered dose inhalers used asthma chronic obstructive pulmonary disease noting meeting parties first time considering essential use nominations submitted parties operating paragraph article noting also medical technical options committee stated report difficulty assessing nominations submitted parties accordance criteria decision iv subsequent relevant decisions owing lack certain information noting notwithstanding insufficient information referred preceding paragraph medical technical options committee gave due consideration health safety patients regard amounts recommended welcoming continued progress several parties operating paragraph article reducing reliance chlorofluorocarbon based metered dose inhalers alternatives developed receive regulatory approval marketed sale authorize levels production consumption necessary satisfy essential uses chlorofluorocarbons metered dose inhalers asthma chronic obstructive pulmonary disease specified annex present decision request nominating parties supply medical technical options committee information enable assessment essential use nominations accordance criteria set decision iv subsequent relevant decisions set handbook essential use nominations encourage parties essential use exemptions consider sourcing required pharmaceutical grade chlorofluorocarbons initially stockpiles available accessible encourage parties stockpiles pharmaceutical grade chlorofluorocarbons potentially available export parties essential use exemptions notify ozone secretariat quantities contact point december request secretariat post website details potentially available stocks referred preceding paragraph request executive committee consider next meeting reviewing chlorofluorocarbon production phase out agreements china india view allowing production pharmaceutical grade chlorofluorocarbons meet authorized levels production consumption specified annex present decision authorized amounts future years parties listed annex present decision shall full flexibility sourcing quantity pharmaceutical grade chlorofluorocarbons extent required manufacturing metered dose inhalers authorized paragraph above either imports domestic producers existing stockpiles request technology economic assessment panel medical technical options committee organize undertake mission experts examine technical economic administrative issues affecting transition cfc metered dose inhalers cfc free alternatives russian federation report results mission meeting thirtieth open ended working group technology economic assessment panel requested examine status transition enterprises manufacturing cfc mdis technical financial logistical administrative barriers transition possible options overcome barriers facilitate transition annex essential use authorizations chlorofluorocarbons metered dose inhalers party argentina bangladesh china egypt india iran islamic republic of pakistan russian federation syrian arab republic note usa exemption authorized decision xx